Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
Adolescent
Antineoplastic Agents
/ adverse effects
Cancer Survivors
/ statistics & numerical data
Child
Cranial Irradiation
/ adverse effects
Delivery of Health Care
/ standards
Evidence-Based Medicine
Humans
Neoplasms
/ drug therapy
Ototoxicity
/ diagnosis
Platinum Compounds
/ adverse effects
Population Surveillance
Young Adult
Journal
The Lancet. Oncology
ISSN: 1474-5488
Titre abrégé: Lancet Oncol
Pays: England
ID NLM: 100957246
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
24
08
2018
revised:
06
11
2018
accepted:
07
11
2018
entrez:
8
1
2019
pubmed:
8
1
2019
medline:
17
4
2020
Statut:
ppublish
Résumé
Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal care and reduce consequent problems-such as speech and language, social-emotional development, and learning difficulties-for these CAYA cancer survivors, clinical practice guidelines for monitoring ototoxicity are essential. The implementation of surveillance across clinical settings is hindered by differences in definitions of hearing loss, recommendations for surveillance modalities, and remediation. To address these deficiencies, the International Guideline Harmonization Group organised an international multidisciplinary panel, including 32 experts from ten countries, to evaluate the quality of evidence for ototoxicity following platinum-based chemotherapy and head or brain radiotherapy, and formulate and harmonise ototoxicity surveillance recommendations for CAYA cancer survivors.
Identifiants
pubmed: 30614474
pii: S1470-2045(18)30858-1
doi: 10.1016/S1470-2045(18)30858-1
pmc: PMC7549756
mid: NIHMS1621017
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Platinum Compounds
0
Types de publication
Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e29-e41Subventions
Organisme : Cancer Research UK
ID : 8156
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014236
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180886
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.
Références
J Clin Oncol. 2016 Apr 10;34(11):1248-55
pubmed: 26811531
Eur J Cancer. 2009 Apr;45(6):992-1005
pubmed: 19231160
Br J Community Nurs. 2005 May;10(5):228-32
pubmed: 15923990
J Pediatr Hematol Oncol. 2004 Oct;26(10):649-55
pubmed: 15454836
Int J Pediatr Otorhinolaryngol. 2016 Nov;90:64-69
pubmed: 27729156
Folia Med (Plovdiv). 2015 Jul-Dec;57(3-4):216-22
pubmed: 27180348
J Otolaryngol. 1994 Jun;23(3):151-9
pubmed: 8064951
Eur J Cancer. 2016 Dec;69:77-85
pubmed: 27821322
Pediatr Blood Cancer. 2004 Jun;42(7):598-603
pubmed: 15127414
Cancer. 2006 Jul 15;107(2):417-22
pubmed: 16779793
Pediatr Blood Cancer. 2013 Mar;60(3):474-8
pubmed: 22744939
Cancer J Sci Am. 1998 Mar-Apr;4(2):110-24
pubmed: 9532413
Pediatrics. 2010 Apr;125(4):e938-50
pubmed: 20194279
Circulation. 2003 Jun 17;107(23):2979-86
pubmed: 12814985
J Pediatr Hematol Oncol. 2007 Jun;29(6):355-60
pubmed: 17551394
N Engl J Med. 2018 Jun 21;378(25):2376-2385
pubmed: 29924955
Int J Pediatr Otorhinolaryngol. 2010 Aug;74(8):913-9
pubmed: 20846503
J Clin Oncol. 1992 Oct;10(10):1592-601
pubmed: 1403039
Cochrane Database Syst Rev. 2016 Aug 03;(8):CD010181
pubmed: 27486906
ASHA. 1981 Jul;23(7):493-500
pubmed: 7052898
J Clin Oncol. 2014 Feb 20;32(6):527-34
pubmed: 24419114
Otolaryngol Head Neck Surg. 2012 Mar;146(3 Suppl):S1-35
pubmed: 22383545
Otolaryngol Head Neck Surg. 2014 Oct;151(2 Suppl):S1-S40
pubmed: 25273878
Lancet Oncol. 2016 Mar;17(3):287-298
pubmed: 26830377
Pediatr Blood Cancer. 2014 Apr;61(4):601-5
pubmed: 24504791
Clin Otolaryngol. 2016 Jun;41(3):276-83
pubmed: 26293165
J Laryngol Otol. 1994 Aug;108(8):637-41
pubmed: 7930910
Eur J Cancer. 2004 Nov;40(16):2445-51
pubmed: 15519518
Pediatr Blood Cancer. 2012 Jun;58(6):953-8
pubmed: 21796767
Pediatr Blood Cancer. 2009 Mar;52(3):387-91
pubmed: 19061216
Pediatr Blood Cancer. 2013 Apr;60(4):543-9
pubmed: 23281199
J Clin Oncol. 2008 Aug 1;26(22):3749-55
pubmed: 18669462
J Neurosurg. 2001 Sep;95(3):432-4
pubmed: 11565864
Laryngoscope. 1991 Sep;101(9):917-24
pubmed: 1886439
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1194-207
pubmed: 15001264
J Pediatr Hematol Oncol. 2008 Feb;30(2):130-4
pubmed: 18376265
Pediatr Blood Cancer. 2005 Sep;45(3):324-32
pubmed: 15714447
J Clin Oncol. 2012 Apr 1;30(10):1034-41
pubmed: 22370329
Audiol Neurootol. 2012;17(5):321-30
pubmed: 22739546
Int J Audiol. 2010 Oct;49(10):765-71
pubmed: 20874050
J Neurosurg Pediatr. 2012 Apr;9(4):421-7
pubmed: 22462709
Kinderkrankenschwester. 2017 Jan;36(1):20-29
pubmed: 30388336
Qual Life Res. 2006 Feb;15(1):143-57
pubmed: 16411038
Cancer. 2016 Jun 1;122(11):1647-58
pubmed: 26859792
Pediatr Blood Cancer. 2018 Mar;65(3):
pubmed: 29230928
J Speech Hear Disord. 1986 Feb;51(1):53-62
pubmed: 3945060
Neuro Oncol. 2014 Jun;16(6):848-55
pubmed: 24414535
Int J Audiol. 2010 Jan;49 Suppl 1:S64-9
pubmed: 19919326
Br Med Bull. 2002;63:171-81
pubmed: 12324392
Ear Hear. 1998 Oct;19(5):339-54
pubmed: 9796643
Pediatr Blood Cancer. 2014 Nov;61(11):2012-7
pubmed: 24976616
No Shinkei Geka. 1997 Apr;25(4):367-71
pubmed: 9125722
Cochrane Database Syst Rev. 2016 Sep 27;9:CD009219
pubmed: 27669661
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Cancer Invest. 2005;23(3):201-7
pubmed: 15945505
Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1631-8
pubmed: 17706797
Braz J Otorhinolaryngol. 2016 Nov - Dec;82(6):623-629
pubmed: 27156673
Pediatr Blood Cancer. 2011 Jul 15;57(1):126-34
pubmed: 21328523
Cancer. 2009 Dec 15;115(24):5828-35
pubmed: 19813275
Lancet Oncol. 2017 Jan;18(1):63-74
pubmed: 27914822
J Clin Oncol. 2012 Jul 1;30(19):2408-17
pubmed: 22547603
Arch Otolaryngol Head Neck Surg. 2004 May;130(5):556-62
pubmed: 15148176
J Neurosurg. 1999 Apr;90(4):773-5
pubmed: 10193625
Pediatrics. 2007 Oct;120(4):898-921
pubmed: 17908777
J Clin Oncol. 2005 Dec 1;23(34):8588-96
pubmed: 16314621
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):892-9
pubmed: 18395355
Int J Audiol. 2011 Oct;50(10):642-51
pubmed: 21812630
JAMA. 2007 Jun 27;297(24):2705-15
pubmed: 17595271
J Pediatr Hematol Oncol. 2013 May;35(4):e138-43
pubmed: 23274376
Int J Pediatr Otorhinolaryngol. 1989 Sep;18(1):21-30
pubmed: 2807751
Pediatr Hematol Oncol. 2017 Mar;34(2):120-129
pubmed: 28590156
Int J Audiol. 2006 Jun;45(6):337-43
pubmed: 16777780
Bone Marrow Transplant. 1998 Oct;22(7):669-74
pubmed: 9818694